Plekha7 promotes retina organization and inhibits inflammation and photoreceptor loss

This study demonstrates that Plekha7 is essential for maintaining retinal organization and preventing photoreceptor loss by regulating cadherin trafficking at apical junctions and influencing centrosome and cilia dynamics, largely independent of p120 catenin.

The Gist

Imagine the retina of your eye as a bustling, highly organized city. In this city, the buildings (cells) need to stand in perfect rows, hold hands tightly with their neighbors, and communicate efficiently to keep the city running smoothly. This paper introduces a new "City Manager" protein called Plekha7 and reveals what happens when this manager goes on strike.

Here is the story of Plekha7, told in simple terms with some creative analogies.

1. The Missing City Manager

In a healthy eye, Plekha7 acts like a super-foreman stationed at the top of the buildings (the cell junctions). Its main job is to make sure the "glue" holding the buildings together stays strong and doesn't get washed away.

The researchers created mice that were born without this foreman (Plekha7 knockout). They expected the mice to be fine because previous studies suggested Plekha7 wasn't essential. But they were wrong. Without Plekha7, the eye city fell into chaos.

2. The Great Collapse: What Happens Without Plekha7?

When the foreman is missing, three major disasters strike the eye city:

• The Buildings Lose Their Shape: The neat rows of cells get messy. The layers of the retina, which should be like a perfectly stacked deck of cards, start to fold and crumple. The city becomes thinner because the buildings are collapsing.
• The "Glue" Disappears: The cells rely on a special molecular glue (called E-cadherin) to stick together. Plekha7's job is to keep this glue on the surface of the cells. Without Plekha7, the glue gets stolen by the cell's internal "trash disposal" system (endocytosis) and thrown away. The buildings lose their grip on each other.
• The Garbage Trucks Arrive: Because the city walls are broken and the buildings are falling apart, the immune system sends in its cleanup crew (microglia). In a healthy eye, these cleanup trucks stay in the parking lot. But in the Plekha7-less eye, they invade the city streets, eating away at the delicate light-sensing cells (photoreceptors), causing blindness.

3. The Big Surprise: The Foreman Doesn't Need His Assistant

For years, scientists thought Plekha7 needed a sidekick named p120 catenin to do its job. They thought Plekha7 was just the boss, and p120 was the one actually holding the glue.

The Twist: The researchers discovered that Plekha7 is actually a lone wolf. Even when they removed the sidekick (p120), Plekha7 could still hold the glue in place. This changes the whole story of how these cells stick together. Plekha7 has its own secret method for keeping the city walls intact, independent of its famous partner.

4. The Hidden Jobs: The Construction Crew and the Antenna

The paper also found that Plekha7 has two other hidden jobs that are crucial for the eye:

• The Construction Crew (Centrosomes & Cilia): Think of the cells as having tiny antennas (cilia) that help them sense their environment. Plekha7 is found at the base of these antennas. Without Plekha7, the construction crew can't build the antennas properly. The cells become "deaf" to their surroundings, which contributes to the city falling apart.
• The Dividing Line (Cytokinesis): When cells need to split into two new cells (like a cell dividing to make a new building), Plekha7 helps draw the line in the sand. Without it, cells sometimes fail to split, resulting in "two-headed" monsters (multinucleated cells) that mess up the city's architecture.

5. Why This Matters for Humans

You might wonder, "If mice without this protein get sick, why don't humans?" The answer is that mice have a backup system (other similar proteins) that can partially fix the problem, which is why the symptoms are subtle in mice.

However, humans have a different situation. We know that mutations in the human version of Plekha7 are linked to serious eye diseases like glaucoma and macular degeneration (which causes blindness). This paper explains why those mutations cause blindness: without Plekha7, the eye's city walls crumble, the glue falls off, and the immune system destroys the light-sensing cells.

The Bottom Line

Plekha7 is the unsung hero of the eye. It's not just a glue-keeper; it's a traffic controller, a construction manager, and a guardian of the city walls. When it's missing, the eye's structure collapses, inflammation takes over, and vision is lost. Understanding this helps scientists figure out how to fix the "glue" and save sight in people with these genetic conditions.

Technical Summary

1. Problem Statement

While PLEKHA7 (Pleckstrin Homology Domain Containing 7) was previously characterized in cultured epithelial cells as a component of apical zonula adherens (ZA) junctions that stabilizes cadherin-catenin complexes and interacts with p120 catenin, its in vivo physiological role remained unclear.

• The Paradox: Constitutive Plekha7 knockout mice and rats were previously reported to be viable with only subtle phenotypes (e.g., blood pressure regulation), suggesting PLEKHA7 is not essential for general epithelial integrity.
• The Clinical Gap: Despite the lack of overt systemic pathology in knockouts, human genetic studies have strongly linked PLEKHA7 variants to eye disorders, including primary angle-closure glaucoma, cleft lip/palate, and reduced macular thickness.
• The Question: Does Plekha7 loss cause specific, severe defects in the murine eye that were previously overlooked, and what are the underlying molecular mechanisms?

2. Methodology

The study employed a multi-faceted approach combining in vivo mouse models with in vitro cell biology:

• Animal Models: Used constitutive Plekha7^-/- knockout mice (ICR/C57BL/6J chimeric background) crossed to generate littermate controls (Plekha7^+/+ and Plekha7^+/-). Retinas were analyzed at various postnatal time points (P21, P60, P108, P360).
• Histology & Imaging:
  • H&E Staining: To assess retinal lamination, thickness, and gross morphology.
  • Immunofluorescence (IF): Used to localize proteins (Plekha7, N-cadherin, p120, $\beta$-catenin, ZO-1, actin) and markers for specific cell types (photoreceptors, microglia, Müller cells).
  • Super-Resolution Microscopy (SR-SIM): Used to visualize centrosomal localization of Plekha7.
  • Whole Mounts: Used for RPE and retinal vascular analysis.
• Cell Culture Models:
  • A431D Cells: Human squamous carcinoma cells lacking endogenous cadherins and Plekha7, used to study ectopic expression of Plekha7 mutants.
  • MDCK, RPE-1, RCTE Cells: Used to study cilia formation, centrosome localization, and cytokinesis.
• Molecular Assays:
  • Cadherin Internalization Assay: Measured E-cadherin endocytosis rates using surface labeling and acid stripping.
  • Live-Cell Imaging: Time-lapse microscopy of MDCK cells expressing RFP-H2B to observe cytokinesis and cell fusion events.
  • qPCR & Western Blot: Confirmed gene/protein knockout and expression levels.

3. Key Contributions & Mechanisms

The paper establishes three distinct but interconnected mechanisms by which Plekha7 maintains retinal homeostasis:

A. Regulation of Cadherin Trafficking (p120-Independent)

• Discovery: Plekha7 is essential for maintaining the accumulation of cadherin-catenin complexes at apical junctions (Outer Limiting Membrane and RPE).
• Mechanism: Plekha7 limits the endocytosis of E-cadherin. In its absence, E-cadherin is internalized more rapidly, reducing junctional pools.
• Novelty: Contrary to the prevailing dogma that p120 catenin is the sole regulator of cadherin stability, the study demonstrates that Plekha7 can recruit to junctions and stabilize cadherins independently of p120. This was proven using p120-uncoupled E-cadherin mutants and p120-deficient cell lines.

B. Centrosome and Cilia Function

• Discovery: Plekha7 localizes to centrosomes and basal bodies of primary cilia.
• Mechanism: Plekha7 regulates tubulin glutamylation, a post-translational modification critical for cilia extension and stability.
• Consequence: Plekha7 loss leads to reduced glutamylated tubulin, defective cilia assembly, and a significant reduction in the length of the photoreceptor inner segment (IS).

C. Cytokinesis and RPE Integrity

• Discovery: Plekha7 localizes to the midbody during cell division.
• Consequence: Loss of Plekha7 leads to cytokinesis defects (failure of cell division) and cell fusion events, resulting in RPE multinucleation. This disrupts the hexagonal packing of the RPE layer and compromises the blood-retina barrier.

4. Key Results

• Retinal Disorganization: Plekha7^-/- retinas exhibit severe lamination defects, including retinal folds and the presence of nuclei in the subretinal space.
• Reduced Retinal Thickness: There is a significant, age-dependent reduction in total retinal thickness, most notably in the Inner Segment (IS) layer.
• Photoreceptor Loss: A marked reduction in cone photoreceptors (Arrestin-positive) is observed, particularly in the equatorial and peripheral retina. Rod photoreceptors and Müller cells remain largely unaffected structurally.
• RPE Pathology: The RPE layer shows irregular cell shapes, loss of apical actin organization, and a high frequency of multinucleated cells.
• Inflammation: There is a massive infiltration of activated microglia (F4/80+, Iba-1+) into the RPE and photoreceptor layers. These microglia exhibit activated morphology (reduced arborization, increased soma size) and likely contribute to photoreceptor degeneration via phagocytosis.
• Vascular/Ciliary Body: While the ciliary body shows junctional disorganization (loss of N-cadherin/p120 localization), gross vascular structure and trabecular meshwork appear normal.

5. Significance

• Resolving the "Knockout Paradox": The study explains why Plekha7^-/- mice were previously thought to be healthy: the defects are highly tissue-specific (retina/RPE) and likely compensated for by family members (Plekha5/6) in other tissues.
• Human Disease Relevance: The findings provide a mechanistic basis for the strong genetic association between PLEKHA7 variants and human retinal diseases, including glaucoma and macular degeneration. The observed reduction in macular thickness in human GWAS studies directly correlates with the IS thinning and photoreceptor loss seen in the mouse model.
• New Paradigm for Junctional Stability: The discovery that Plekha7 regulates cadherin trafficking independently of p120 challenges existing models of adherens junction maintenance and suggests a more complex regulatory network involving distinct trafficking pathways.
• Therapeutic Implications: By linking junctional instability, ciliary defects, and inflammation to a single protein, the study highlights Plekha7 as a potential target for preventing retinal degeneration and managing inflammatory eye diseases.

In summary, this paper redefines Plekha7 as a critical, non-redundant regulator of retinal architecture, acting through the dual mechanisms of stabilizing apical junctions (via cadherin trafficking) and maintaining ciliary/centrosomal function, with the loss of these functions triggering a cascade of inflammation and photoreceptor death.